Literature DB >> 4032558

Papillary adenocarcinoma in situ of bladder.

A M O'Brien, S J Urbanski.   

Abstract

To the best of our knowledge papillary adenocarcinoma in situ of the bladder has not been reported previously. We describe a case of transitional cell carcinoma in situ of the bladder associated with papillary adenocarcinoma in situ. While it is believed that most nonurachal adenocarcinomas of the bladder originate within cystitis glandularis, such transition is difficult to document. We assume that severe dysplasia of a papillary adenomatous component adjacent to papillary adenocarcinoma in situ represents an intermediate morphological change between cystitis glandularis and adenocarcinoma. Electron microscopic evaluation of glandular epithelium indicates that it represents the process of aberrant differentiation rather than a metaplastic phenomenon.

Entities:  

Mesh:

Year:  1985        PMID: 4032558     DOI: 10.1016/s0022-5347(17)47286-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Mucinous adenocarcinoma with superficial stromal invasion and villous adenoma of urachal remnants: a case report.

Authors:  R Mazzucchelli; M Scarpelli; R Montironi
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Cystoprostatectomy with ileal neobladder for treatment of severe cystitis glandularis in an AIDS patient.

Authors:  Rafael Ferreira Coelho; Giovanni Scala Marchini; Marcos Francisco Dall'oglio; Mabel Tatty de Medeiros; Adriano João Nesrallah; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

Review 3.  Concurrence of villous adenoma and non-muscle invasive bladder cancer arising in the bladder: a case report and review of the literature.

Authors:  Yoichiro Kato; Susumu Konari; Wataru Obara; Tamotsu Sugai; Tomoaki Fujioka
Journal:  BMC Urol       Date:  2013-07-20       Impact factor: 2.264

4.  Cystitis glandularis: A controversial premalignant lesion.

Authors:  Xianlin Yi; Haoyuan Lu; Yuexian Wu; Yang Shen; Qinggui Meng; Jiweng Cheng; Yong Tang; Fengxue Wu; Rubiao Ou; Shaojun Jiang; Xianzhong Bai; Keji Xie
Journal:  Oncol Lett       Date:  2014-07-18       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.